Literature DB >> 16521042

Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis.

Riitta Kaarteenaho-Wiik1, Lauri Lammi, Essi Lakari, Vuokko L Kinnula, Juha Risteli, Lasse Ryhänen, Paavo Pääkkö.   

Abstract

The aim of this study was to assess and compare the accumulation and distribution of newly synthesized type I and III collagens in usual interstitial pneumonia (UIP) and pulmonary sarcoidosis. Lung biopsies from 10 patients with UIP and 13 patients with sarcoidosis were investigated by immunohistochemical technique and mRNA in situ hybridization. The antibodies for the aminoterminal propeptide of type I procollagen and the aminoterminal propeptide of type III procollagen (PINP and PIIINP, respectively) were used. When compared to healthy lung, levels of type I pN- and type III pN-collagens were increased in both of these disorders. Type I procollagen was mostly present as intracellular spots in newly formed fibrosis in UIP while type III pN-collagen was expressed extracellularly underneath metaplastic alveolar epithelium. Type I procollagen was present intracellularly within and around the granulomas of sarcoidosis, whereas type III pN-collagen was expressed extracellularly, mainly around the granulomas. mRNAs of both collagens colocalized with the precursor proteins. We conclude that the expression of precursor proteins and mRNA of type I and type III collagens is increased in UIP and sarcoidosis, reflecting mainly active synthesis of these collagens in different areas of the lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521042     DOI: 10.1007/s10735-006-9018-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  49 in total

Review 1.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

2.  Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation.

Authors:  H Kuivaniemi; G Tromp; M L Chu; D J Prockop
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

3.  Aberrant type I and type III collagen gene expression in human breast cancer in vivo.

Authors:  S Kauppila; F Stenbäck; J Risteli; A Jukkola; L Risteli
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

4.  Proteoglycan deposition in pulmonary fibrosis.

Authors:  E S Bensadoun; A K Burke; J C Hogg; C R Roberts
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

5.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

6.  Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene.

Authors:  M P Bernard; J C Myers; M L Chu; F Ramirez; E F Eikenberry; D J Prockop
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

7.  Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms.

Authors:  G G Zhu; L Risteli; M Mäkinen; J Risteli; A Kauppila; F Stenbäck
Journal:  Cancer       Date:  1995-02-15       Impact factor: 6.860

8.  Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study.

Authors:  K Zhang; M D Rekhter; D Gordon; S H Phan
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.

Authors:  T Sakai; H Kawakatsu; M Ohta; M Saito
Journal:  J Cell Physiol       Date:  1994-06       Impact factor: 6.384

10.  Extracellular matrix in normal and fibrotic human lungs.

Authors:  G Raghu; L J Striker; L D Hudson; G E Striker
Journal:  Am Rev Respir Dis       Date:  1985-02
View more
  4 in total

1.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

2.  Variability in the precursor proteins of collagen I and III in different stages of COPD.

Authors:  Terttu Harju; Vuokko L Kinnula; Paavo Pääkkö; Kaisa Salmenkivi; Juha Risteli; Riitta Kaarteenaho
Journal:  Respir Res       Date:  2010-11-30

Review 3.  Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis.

Authors:  Jincheng Wang; Kaili Hu; Xuanyan Cai; Bo Yang; Qiaojun He; Jiajia Wang; Qinjie Weng
Journal:  Acta Pharm Sin B       Date:  2021-07-29       Impact factor: 11.413

4.  Non-Canonical Regulation of Type I Collagen through Promoter Binding of SOX2 and Its Contribution to Ameliorating Pulmonary Fibrosis by Butylidenephthalide.

Authors:  Hong-Meng Chuang; Li-Ing Ho; Mao-Hsuan Huang; Kun-Lun Huang; Tzyy-Wen Chiou; Shinn-Zong Lin; Hong-Lin Su; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2018-10-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.